| |
|
|
Board of Directors
Michael Barnes, CEO
Mr. Barnes has over twenty years of experience developing and leading advanced remote sensing programs for detection of low-observable high-value phenomenon. As a proven entrepreneur, Mr. Barnes has successfully founded and managed new ventures which leverage high concept detection technologies in providing unique information based services across the government and commercial sectors. Operating across a variety of risk levels his experience encompasses the full range of remote sensing applications involving airborne, groundborne and human imaging scenarios. Mr. Barnes graduated with an M.S. in Physics from the University of South Florida.
Dr. Douglas Lind, M.D., Managing Partner- GBP Capital
Douglas Lind, managing partner at GBP Capital, has more than 20 years of experience in a variety of life science related professions, ranging from former practicing physician to senior Wall Street equity research analyst. Most recently, he was Founder and Managing Partner of Accendx Management, LLC, a Greenwich, CT based public equity fund formed in 2003. Prior, he was senior biotechnology equity research analyst at Morgan Stanley from 1997 through 2002 and at PaineWebber from 1995 to 1997. Previously, he was founder and Managing Director of Lind & Co., a Boston-based biotechnology investment research firm. He is a former Tufts University Clinical Fellow in Medicine and a past member of the American Medical Association Council on Ethical and Judicial Affairs. He has served on numerous national health policy bodies, including the Health Policy Agenda for the American People and the American Medical Association Task Force on Physician Manpower. Dr. Lind is a graduate of the University of Iowa College of Medicine, 1987. From 1990 to 1992, he was a practicing physician in Brookline, Massachusetts. He served as an attending physician at St. Elizabeth's Hospital in Boston, a major teaching affiliate of Tufts University School of Medicine, where he completed his residency training in Internal Medicine.
David Wetherell, Founder and Managing Partner- GBP Capital
David Wetherell has spent 20 years as a CEO in high-tech businesses, as well as 11 years in venture capital. His career began in software development in a variety of industries. He founded a software company, Softrend, Inc., in 1982. While at Softrend, he developed software allowing PCs to access and to download data from corporate mainframes and integrated office software tool suites for desktop computers. He led a leveraged buyout of a direct marketing company, College Marketing Group, and transformed it into CMGI (NASDAQ: CMGI). While operating that company from 1986 to 2002, its sales rose from $3 million to over $1 billion annually. There he started numerous Internet companies and one of the first internet venture capital funds, @Ventures, which was responsible for the first investments in a number of key early companies in the Internet, including Lycos (IPO and later sold to Terra Networks), GeoCities (IPO and later sold to Yahoo), Half.com (sold to eBay), Vicinity (now, Microsoft's mapping technology), PlanetAll (sold to Amazon.com), WebCT (acquired by Blackboard), and MyFamily.com (also known as Ancestry.com, which was acquired by a private equity firm).
Until August, 2006, Mr. Wetherell served as chairman of CMGI, which has directed its venture capital efforts to clean energy technologies and owns ModusLink, one of the largest supply chain management companies in the world serving the high tech industry.
Mr. Wetherell founded GBP Capital, a Greenwich, CT-based private equity firm focused on financing innovation in the life sciences in 2005. Mr. Wetherell has received numerous awards, including Ernst and Young's New England Entrepreneur of the Year, in 2000 and Money magazines Top 25 investors. He obtained his BA in Mathematics from Ohio Wesleyan University and an honorary doctorate from Bryant University.
|
|